|
|
|
|
| LEADER |
02926nam a2200493 4500 |
| 001 |
ocn854681015 |
| 003 |
OCoLC |
| 005 |
20180501122012.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130730s2013 caua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d UIU
|d IDEBK
|d E7B
|d YDXCP
|d GGVRL
|d OCLCF
|d OCLCQ
|d EBLCP
|d UKDOC
|d OCLCQ
|d ESU
|d OCLCQ
|e rda
|d MEU
|d GrThAP
|
| 019 |
|
|
|a 865329780
|a 911689902
|
| 020 |
|
|
|a 9780124055377
|q (electronic bk.)
|
| 020 |
|
|
|a 0124055370
|q (electronic bk.)
|
| 020 |
|
|
|a 9780124058804
|
| 020 |
|
|
|a 0124058809
|
| 035 |
|
|
|a (OCoLC)854681015
|z (OCoLC)865329780
|z (OCoLC)911689902
|
| 050 |
|
4 |
|a RM411
|
| 050 |
|
4 |
|a RM30
|b .A42 v.67eb
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7924
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Anti-Viral Agents /
|c edited by Erik De Clercq.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a San Diego, CA :
|b Academic Press,
|c 2013.
|
| 300 |
|
|
|a 1 online resource (xiv, 369 pages :
|b illustrations).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in pharmacology ;
|v 67
|
| 546 |
|
|
|a Text in English.
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a 1. Antiviral agents for herpes simplex virus / R. Anthony Vere Hodge and Hugh J. Field -- 2. Nucleotide prodrugs for the treatment of HCV infection / Michael J. Sofia -- 3. HIV integrase inhibitors : 20-year landmark and challenges / Mathieu Metifiot, Christophe Marchand, and Yves Pommier -- 4. Advances in the treatment of varicella-zoster virus infections / G. Andrei and R. Snoeck -- 5. Hepatitis C virus : standard-of-care treatment / Jean-Michel Pawlotsky -- 6. Influenza virus resistance to antiviral therapy / Erhard van der Vries [and four others] -- 7. The natural course of chronic hepatitis B virus infection and its management / Stephanos J. Hadziyannis, Dimitrios Vassilopoulos, and Emilia Hadziyannis -- 8. The Holy Trinity : the acyclic nucleoside phosphonates / Erik De Clercq -- 9. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS) / Erik De Clercq.
|
| 520 |
|
|
|a This book explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV.
|
| 650 |
|
0 |
|a Antiviral agents.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Antiviral agents.
|2 fast
|0 (OCoLC)fst00810869
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a De Clercq, Erik,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Anti-viral agents
|z 9780124058804
|w (OCoLC)853505663
|
| 830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v v. 67.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/10543589/67
|z Full Text via HEAL-Link
|
